Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Transfection Reagents & Equipment Market - Global Forecast 2026-2032 | Market to Reach USD 2.43 Billion as Cell and Gene Therapy, mRNA, CRISPR, and GMP Automation Drive 7.18% CAGR

globenewswire.com

Transfection Reagents & Equipment Market - Global Forecast 2026-2032 | Market to Reach USD 2.43 Billion as Cell and Gene Therapy, mRNA, CRISPR, and GMP Automation Drive 7.18% CAGR Dublin, Nov. 19, 2026 (GLOBE NEWSWIRE) -- "Transfection Reagents & Equipment Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

This market research report examines the global transfection reagents and equipment market, projected to grow from USD 1.60 billion in 2026 to USD 2.43 billion by 2032 at a CAGR of 7.18%. It analyzes the technologies, applications, regional dynamics, and competitive priorities shaping nucleic acid and protein delivery across life sciences research, biomanufacturing, and therapeutic development.

Market Growth and Demand Drivers

Transfection technologies enable nucleic acids, proteins, and gene-editing systems to enter cells for applications spanning cell and gene therapy, RNA therapeutics, vaccine research, oncology, immunology, functional genomics, and synthetic biology. Demand is supported by the need for reliable delivery into primary cells, stem cells, immune cells, and other difficult-to-transfect cell lines.

Clinical validation of mRNA vaccines, CAR-T therapies, adeno-associated virus gene therapies, and CRISPR-based treatments is increasing demand across research, process development, and quality-controlled manufacturing. Suppliers are differentiating through higher cell viability, reduced cytotoxicity, scalable platforms, animal-origin-free chemistries, closed-system compatibility, and application-specific protocols.

Technology and Workflow Shifts

These insights support strategic planning by clarifying where scalable, regulatory-aligned solutions are replacing general-purpose laboratory products.

Artificial Intelligence in Transfection

Artificial intelligence is improving experimental design, protocol optimization, and quality prediction. Machine learning can evaluate cell type, payload, reagent ratio, pulse parameters, viability, and expression outcomes to identify effective conditions with less trial and error-particularly valuable when working with limited patient-derived or primary-cell samples.

AI also supports formulation development, predictive instrument maintenance, automated image-based efficiency assessment, and digital quality control. Integration with laboratory information management systems, electronic lab notebooks, and imaging platforms can improve documentation and reduce workflow variability.

Regional Market Insights

Regional comparisons help organizations assess market-entry priorities, tailor pricing and training models, and mitigate regulatory or supply-chain risks.

Competitive and Commercial Priorities

Industry participants should build application-specific portfolios for mRNA delivery, CRISPR editing, immune-cell engineering, viral vector production, and transient protein expression. Key differentiators include validated protocols, difficult-cell performance, GMP documentation, lot-to-lot consistency, and smooth progression from discovery to manufacturing.

Investment in automation, digital protocol libraries, closed systems, and AI-enabled optimization can strengthen competitive positioning. Partnerships with contract development organizations, academic core facilities, hospitals, and cell therapy centers can accelerate adoption and generate credible application data.

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transfection Reagents & Equipment Market, by Product Type

7.1. Introduction

7.2. Transfection Reagents

7.2.1. Lipid-based Transfection Reagents

7.2.2. Polymer-Based Reagents

7.2.3. Calcium Phosphate Reagents

7.3. Transfection Equipment

7.3.1. Electroporation Systems

7.3.2. Microinjection Systems

8. Transfection Reagents & Equipment Market, by Technology Type

8.1. Introduction

8.2. Chemical Methods

8.3. Physical Methods

8.4. Viral Methods

9. Transfection Reagents & Equipment Market, by Molecule Type

9.1. Introduction

9.2. Plasmid DNA

9.3. shRNA

9.4. mRNA

9.5. CRISPR-Cas9 RNP complexes

9.6. Oligonucleotides

10. Transfection Reagents & Equipment Market, by Transfection Mode

10.1. Introduction

10.2. Transient Transfection

10.3. Stable Transfection

10.4. Episomal Expression Systems

11. Transfection Reagents & Equipment Market, by Application

11.1. Introduction

11.2. Gene Expression Studies

11.3. Protein Production

11.4. Drug Discovery & Development

11.5. Gene Therapy & Cell Therapy

11.6. Vaccine Development

12. Transfection Reagents & Equipment Market, by Region

12.1. Introduction

12.2. Asia-Pacific

12.3. North America

12.4. Latin America

12.5. Europe

12.6. Middle East

12.7. Africa

13. Transfection Reagents & Equipment Market, by Group

13.1. Introduction

13.2. ASEAN

13.3. GCC

13.4. European Union

13.5. BRICS

13.6. G7

13.7. NATO

14. Transfection Reagents & Equipment Market, by Country

14.1. Introduction

14.2. United States

14.3. Canada

14.4. Mexico

14.5. Brazil

14.6. United Kingdom

14.7. Germany

14.8. France

14.9. Russia

14.10. Italy

14.11. Spain

14.12. China

14.13. India

14.14. Japan

14.15. Australia

14.16. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025

15.2. Market Concentration Analysis, 2025

15.2.1. Concentration Ratio (CR)

15.2.2. Herfindahl Hirschman Index (HHI)

15.3. Recent Developments & Impact Analysis, 2025

15.4. Product Portfolio Analysis, 2025

15.5. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Agilent Technologies, Inc.

16.2. Altogen Biosystems

16.3. Becton, Dickinson and Company

16.4. Bio-Rad Laboratories, Inc.

16.5. Bio-Techne Corporation

16.6. Biontex Laboratories GmbH

16.7. Celetrix LLC

16.8. GeneCopoeia Inc.

16.9. Lonza Group AG

16.10. MaxCyte, Inc.

16.11. Merck KGaA

16.12. Mirus Bio LLC

16.13. Novogene Corporation

16.14. OriGene Technologies, Inc.

16.15. Polyplus-transfection SA

16.16. Promega Corporation

16.17. QIAGEN N.V.

16.18. Revvity

16.19. Roche Holding AG

16.20. Sartorius AG

16.21. SignaGen Laboratories

16.22. Takara Bio Inc.

16.23. Thermo Fisher Scientific Inc.

17. Key Experts

List of Figures [21]

List of Tables [297]

For more information about this report visit https://www.researchandmarkets.com/r/wi6ase

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.